-

Half Year Median Technologies Liquidity Contract Statement

SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--Regulatory News:

Under the liquidity contract entrusted by Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, “Median” or “the Company”) to TP ICAP (Europe), the following resources were listed in the liquidity account as of December 31, 2025:

  • 37,758 shares
  • €166,854.84 in cash.

Transactions during the second half of 2025:

BUY

363,473 shares

991,855.31 EUR

582 transactions

SELL

386,523 shares

1,101,296.51 EUR

506 transactions

For information, as of June 30, 2025, the following resources were listed in the liquidity contract:

  • 60,808 shares
  • €58,893.66 in cash

For information, as of May 4th, 2020, when the new liquidity contract was set up, the following resources were listed in the liquidity account:

  • 4,404 shares
  • €173,829.64 in cash

The daily transaction table is provided in the appendix to this press release. TP ICAP (Europe) is authorized and regulated by the Autorité de Contrôle Prudentiel (ACPR) and the Autorité des Marchés Financiers (AMF).

About Median Technologies: Pioneering innovative software as a medical device and imaging services, Median Technologies harnesses cutting-edge AI to enhance the accuracy of early cancer diagnoses and treatments. Median's offerings include iCRO, which provides medical image analysis and management in oncology trials, and eyonis®, an AI/ML tech-based suite of software as a medical device (SaMD). Median empowers biopharmaceutical entities and clinicians to advance patient care and expedite the development of novel therapies. The French-based company, with a presence in the U.S. and China, trades on the Euronext Growth market (ISIN: FR0011049824, ticker: ALMDT). Median is also eligible for the French SME equity savings plan scheme (PEA-PME). For more information, visit www.mediantechnologies.com.

APPENDIX: DAILY TRANSACTIONS

BUY

SALE

ALMDT FP

Number of transactions

Number of shares

Volumes in EUR

Number of transactions

Number of shares

Volumes in EUR

Total

582

363,473

991,855.31

506

386,523

1,101,296.51

20250701

6

4,751

6,933.91

10

12,451

20,504.11

20250702

6

5,191

8,510.59

4

2,741

4,900.91

20250703

2

1,501

2,401.63

11

12,671

22,640.83

20250704

2

36

81.44

11

10,191

25,793.34

20250707

10

9,411

20,576.33

1

1

2.33

20250708

2

1,011

2,123.11

1

1

2.11

20250709

6

5,351

10,806.30

1

1

2.10

20250710

2

61

123.28

11

11,501

26,778.78

20250711

10

10,371

24,833.84

1

1

2.44

20250714

10

8,351

19,037.61

1

1

2.31

20250715

5

2,311

5,150.30

2

1,231

2,855.90

20250716

8

5,371

11,523.43

1

1

2.23

20250717

5

1,961

4,017.30

2

1,371

2,933.90

20250718

2

811

1,686.94

1

1

2.14

20250721

2

801

1,634.06

1

1

2.06

20250722

11

6,051

11,385.09

1

1

1.89

20250723

5

1,561

2,760.80

5

4,661

8,649.60

20250724

7

3,551

6,127.39

6

6,631

12,396.79

20250725

7

3,811

7,109.76

5

4,211

8,398.52

20250728

5

2,101

3,841.86

5

4,241

8,124.26

20250729

1

1

2.04

7

8,031

17,015.14

20250730

6

3,881

8,148.17

2

1,171

2,576.17

20250731

1

1

2.19

11

13,441

31,717.29

20250801

11

10,151

22,874.16

1

1

2.26

20250804

8

7,191

13,299.48

3

1,661

3,241.88

20250805

2

1,111

2,110.93

4

3,081

6,073.73

20250806

6

4,021

7,637.76

3

1,791

3,531.56

20250807

5

2,621

4,897.49

3

1,831

3,537.09

20250808

1

1

1.96

6

5,861

11,986.16

20250811

4

3,491

7,081.65

1

1

2.05

20250812

1

1

2.15

1

1

2.15

20250813

7

4,301

9,809.75

2

1,271

3,050.35

20250814

1

1

2.29

11

14,171

35,868.09

20250815

6

4,211

11,003.85

4

2,461

6,771.05

20250818

5

2,711

7,180.34

7

6,231

17,938.94

20250819

9

8,111

20,637.85

1

1

2.65

20250820

1

1

2.51

4

2,801

7,258.51

20250821

9

7,401

17,942.76

1

1

2.56

20250822

2

1,021

2,368.72

6

3,762

9,213.30

20250825

2

1,031

2,618.79

6

5,321

14,476.39

20250826

10

7,364

18,551.59

1

1

2.59

20250827

9

5,871

14,233.72

2

1,261

3,253.32

20250828

6

2,307

5,500.01

1

1

2.45

20250829

1

1

2.43

4

3,371

8,398.43

20250901

8

4,761

11,357.09

4

3,231

8,243.49

20250902

6

2,921

6,775.22

2

1,381

3,342.02

20250903

2

59

138.12

11

15,011

39,194.60

20250904

2

1,151

3,222.94

5

3,271

9,681.74

20250905

1

1

2.86

11

11,181

34,260.46

20250908

2

1,531

4,623.63

11

8,581

28,659.63

20250909

6

6,311

21,487.45

4

1,201

4,275.05

20250910

1

1

3.48

9

5,211

19,191.08

20250911

6

6,291

21,671.10

4

1,191

4,336.50

20250912

6

5,981

19,646.37

1

1

3.37

20250915

7

7,091

22,409.38

4

1,771

5,985.98

20250916

8

8,117

24,331.94

4

2,041

6,513.74

20250917

5

3,161

9,121.55

3

1,401

4,191.35

20250918

1

1

3.00

6

4,251

13,205.20

20250919

2

1,091

3,360.31

4

2,611

8,332.71

20250922

4

2,311

7,036.95

4

2,511

7,963.25

20250923

11

8,911

26,047.07

1

1

2.97

20250924

8

5,101

14,353.52

1

1

2.92

20250925

6

2,701

7,328.17

1

1

2.77

20250926

1

1

2.70

4

3,351

9,219.90

20250929

1

1

2.75

1

1

2.75

20250930

5

1,821

5,150.88

4

3,181

9,388.28

20251001

1

1

2.96

11

14,041

42,811.66

20251002

1

1

3.36

10

9,381

33,247.16

20251003

8

7,681

27,110.32

3

1,151

4,284.47

20251006

8

6,801

22,780.88

5

2,821

10,131.48

20251007

7

5,201

16,644.10

4

2,461

8,296.90

20251008

5

2,571

8,139.07

5

3,261

10,822.32

20251009

5

2,621

8,349.68

4

1,557

5,127.12

20251010

8

6,061

18,772.24

2

1,091

3,556.64

20251013

1

1

2.98

4

2,861

8,786.98

20251014

5

2,521

7,527.03

4

2,721

8,465.83

20251015

1

1

3.05

5

3,381

10,605.85

20251016

2

55

174.94

4

2,541

8,363.42

20251017

6

4,161

13,334.68

1

1

3.28

20251020

1

1

3.17

4

2,631

8,449.17

20251021

5

2,771

8,772.05

2

1,051

3,426.25

20251022

6

3,901

12,112.06

3

1,099

3,582.74

20251023

1

1

3.07

4

2,681

8,448.87

20251024

6

3,861

12,141.99

4

2,561

8,429.19

20251027

5

2,601

8,025.95

1

1

3.15

20251028

10

7,201

21,098.08

1

1

3.08

20251029

6

2,518

6,859.27

2

1,311

3,749.33

20251030

4

1,541

4,392.68

5

4,031

12,080.48

20251031

5

2,021

5,921.53

4

3,091

9,617.33

20251103

7

3,775

11,049.94

1

1

2.98

20251104

6

2,791

7,890.84

3

1,355

3,983.76

20251105

5

1,771

5,146.12

1

1

2.92

20251106

8

3,861

10,892.30

1

1

2.90

20251107

1

1

2.77

5

6,941

19,861.57

20251110

1

1

2.87

5

4,031

11,654.07

20251111

1

1

2.90

4

3,021

8,976.70

20251112

1

1

3.00

5

3,581

11,090.00

20251113

1

1

3.20

5

3,351

10,870.00

20251114

6

4,221

12,936.51

1

1

3.11

20251117

6

3,801

11,421.27

1

1

3.07

20251118

6

3,491

10,070.96

2

1,221

3,662.96

20251119

6

3,271

9,332.53

1

1

2.93

20251120

1

1

2.93

4

3,201

9,362.93

20251121

5

2,311

6,398.20

1

1

2.80

20251124

1

1

2.77

7

7,043

20,618.69

20251125

1

1

3.04

4

2,801

8,603.04

20251126

1

1

3.13

3

2,451

7,768.13

20251127

5

2,921

8,896.50

1

1

3.10

20251128

1

1

3.12

5

3,341

10,680.52

20251201

6

4,091

13,110.28

1

1

3.28

20251202

1

1

3.30

4

2,731

9,012.30

20251203

6

3,981

12,678.47

1

1

3.27

20251204

4

2,101

6,534.13

2

1,171

3,747.13

20251205

5

2,391

7,425.78

1

1

3.18

20251208

8

5,371

15,884.10

1

1

3.10

20251209

1

1

3.15

11

14,571

47,136.65

20251210

7

5,591

17,669.05

2

154

508.15

20251211

5

2,601

7,973.93

1

1

3.13

20251212

1

1

3.14

4

2,901

9,200.34

20251215

1

1

3.20

5

3,421

11,210.20

20251216

6

4,111

13,092.63

1

1

3.23

20251217

4

2,131

6,797.85

5

3,491

11,648.85

20251218

1

1

3.51

6

5,041

18,303.41

20251219

6

3,981

14,270.84

4

2,461

9,202.84

20251222

2

1,051

4,035.84

11

11,291

47,881.04

20251223

7

5,521

24,374.70

4

1,508

7,012.54

20251224

1

1

4.34

4

2,221

9,859.94

20251225

0

0

0.00

0

0

0.00

20251226

0

0

0.00

0

0

0.00

20251229

1

1

4.50

6

2,703

12,414.34

20251230

4

2,501

11,429.66

4

1,971

9,357.66

20251231

2

1,241

5,658.97

4

1,991

9,412.77

 

Contacts

MEDIAN TECHNOLOGIES
Emmanuelle Leygues
VP, Corporate Marketing & Financial Communications
+33 6 10 93 58 88
emmanuelle.leygues@mediantechnologies.com

Investors - SEITOSEI ACTIFIN
Ghislaine Gasparetto
+33 6 85 36 76 81
ghislaine.gasparetto@seitosei-actifin.com

Press – ULYSSE COMMUNICATION
Bruno Arabian
+33 6 87 88 47 26
barabian@ulysse-communication.com
Nicolas Entz
+33 6 33 67 31 54
nentz@ulysse-communication.com

Median Technologies

BOURSE:ALMDT

Release Versions

Contacts

MEDIAN TECHNOLOGIES
Emmanuelle Leygues
VP, Corporate Marketing & Financial Communications
+33 6 10 93 58 88
emmanuelle.leygues@mediantechnologies.com

Investors - SEITOSEI ACTIFIN
Ghislaine Gasparetto
+33 6 85 36 76 81
ghislaine.gasparetto@seitosei-actifin.com

Press – ULYSSE COMMUNICATION
Bruno Arabian
+33 6 87 88 47 26
barabian@ulysse-communication.com
Nicolas Entz
+33 6 33 67 31 54
nentz@ulysse-communication.com

More News From Median Technologies

Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of December 31, 2025

SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares 36,751,358 Number of real voting rights* (excluding treasury shares**) 36,690,400 Theoretical number of voting rights* (including treasury shares**) 36,728,158 (*) Class E preference shares are non-voting (**) pursuant to article 223-11 of the AMF’s General Regulations About Median Technologies: Pioneering innovative software as a medical device and imaging services, Median Tech...

Median Technologies Partners With Leading U.S. Healthcare Company to Bring eyonis® LCS to Patients Across the U.S. and Europe

SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, “Median” or the “Company”), manufacturer of eyonis® , a suite of artificial intelligence (AI) powered Software as a Medical Device (SaMD) for early cancer diagnosis, and a globally leading provider of AI-based image analyses and central imaging services for oncology drug developers, today announced the signing of a non-exclusive global commercial distribution agreement...

Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of November 30, 2025

SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares 36,741,587 Number of real voting rights* (excluding treasury shares**) 36,669,667 Theoretical number of voting rights* (including treasury shares**) 36,718,387 (*) Class E preference shares are non-voting (**) pursuant to article 223-11 of the AMF’s General Regulations About Median Technologies: Pioneering innovative software as a medical device and imaging services, Median Tech...
Back to Newsroom